{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"lipe-related-familial-partial-lipodystrophy","columns":[{"gene":"","key":"population-ed5d31494f06a636fe49","label":"Lipodystrophy, familial partial, type 6","mondoId":"MONDO:0014431","onsetQualifier":null,"originColumnKey":"MONDO:0014431/OMIM:615980","originalViews":[{"key":"MONDO:0014431/OMIM:615980","label":"Lipodystrophy, familial partial, type 6","scopeLabel":"OMIM:615980","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0cf0b7ae8443af8ffd8a10640dae232fd52da1dd9d8210f3df304a436032d36d","176fc543ba2dfb4250a62e2056040315e5b2a64c1ec1edc1bbedcd93283e091a","17d0089846b8b4c07ed74e36777f990d59ca5912000b6f6290d8ab3f830e9fba","1fad92d965e6791b90f8db8cfee1c4bf5851d84684a0690c08279c69d9832b9e","24084e7ea4d9a30c83a7f31764b50e59a143629d55fea9443fcd50cdc100de4c","2b29ab52da59b0197f1eee1a357f582babec06a9cbc54f0ddd2c9d6de50967ee","2bf4425c9e71b8e240ea01106cce4f7ecfafd25000e228622184123ed5644229","40ad7881a226b42b7d0e6945f2ed62748ca592745eeed6c6dc43c196e9904aff","6665ad7e2dc4fbdd184b3961a04ce988e6ed46e3ea82450dc4029e66c0dedb15","6f80700fe2ecbee6e1cb8c3044aade94541518c35779cc9e35292467c9b8e511","788581fe58880305e1d3c8136002085e4f07ded5b7a27edb7cc81420755022ec","7fd09ed3eeec9adde7daff5f5572e1c80c85c44c0066a070f8d6145532ded9e3","89f9f335561f32a0352c530205c48763ca2182071782117f1f2fc1870dfda54e","8b37a0e18ec2d63b3f10e3c5cb88674ee43ad7b68ca02595f7a415272694b8f7","99867ea78d8e06a1698caec5a76a5c1e50e95700de2c2100f8c461f75d9f5ac9","a7ed306f4be2e660ebf9cd3bdbe5e717488e1229ab5ca353993dfdcdcc4b83bf","b2b334f2a2a19924bab861904a0cac16f38b9989c5381f7d7c0ed2ab6424ae7d","d161ad7a32f3ca86c7e8011d112cb86b23b6858bbcb5d42c8af501cc58995e37","e5a18b45c93dee68a010cd34d946f12c930a261dbdccbe97111806f695f8e05b","f83fd02f3b0960b50b553ab84d554057a584cba27185565a7f69fa32c10c6b2f"],"recordQualifiers":{},"scopeLabel":"OMIM:615980","sourceIds":["OMIM:615980"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-ab0798effa77142bd3ca","label":"LIPE-related familial partial lipodystrophy","mondoId":"MONDO:0014431","onsetQualifier":null,"originColumnKey":"MONDO:0014431/ORPHA:435660","originalViews":[{"key":"MONDO:0014431/ORPHA:435660","label":"LIPE-related familial partial lipodystrophy","scopeLabel":"ORPHA:435660","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1995ff56fe9bec38956de583ba4650e0d043653d8ed4099d4216c6a593ee3b06","364dc37b3af69b1a5e578d9367ab618f34a0955604c41e6bc3d26b6801a3bae9","43a9f318b6769e0334bc77b6244ee3f5a76ef83aeb4cbfff89f984a4229e7dbc","587a5e1557714c655fa8ef1bb17db2ae5337c43c009efa5a4eba3b3f1342dda4","666d9247bd3a303ff7c2704319c3e18e76462eed685dd7da58bb4550c1711d53","6b13113857d10c6366956c4be290d2387f45c4f1704c598011d7ce6127eae6ce","70fdbeb8953ddf118c60d6011cec970c638ed48b4cac48b4c6764e5705848395","755a6a5b0e38fb6708a065373338c6f6de37a1eeefe280a260e1beb23cd93f6f","7a59a9d6d8c2bd9d004db1853189ddc6bdfb398ad56b541b5363342ed275566c","87d713f5f71441959fd34b67dbf00dcbe9de686ca0a5a1c89007358ad6da27df","8909c2b4e5f0f5af620f806b3f5ee31beb9e6867867b65b5e796cf64d7c86ee1","96fc231044aa7ec3961dcd74eea7989d09ab9943cd19bc2dcc4f57159c27df90","a216b4653cc321471c5a7b4314d86bb01a97f4b936ec852604fcdebfeb72a831","ac26014f0f9697aa37516b96287367cf0c0a5e818030830f9940272db2c2f6bf","b27ab33009e5d3a505a9472ea5774b704321459263f19d8f63b9f41a49ca269e","c15e9b6deecd990c9701aa193c0bac89e934c389d9873d2d6ff6cfc1c3dd288f","ce6f33a454b2e93f576094737b4448d093a4e388c2f65fba8429760ff83edc51","cf3084c077c547d2e73e1a15045c728872945f87c1aacc705fb71961ef3c6d47","db7f57414e29a6fbaf0bf6715d6a391bea7e63690e7c495b56f2207d43082872","fce2f01e4f907a3a0c69544fa8d0809c640b14d31c8f9c0560cc049a99755b2f"],"recordQualifiers":{},"scopeLabel":"ORPHA:435660","sourceIds":["ORPHA:435660"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-ed5d31494f06a636fe49","population-ab0798effa77142bd3ca"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012743","HP:0003119","HP:0012881","HP:0000956","HP:0030685","HP:0003292","HP:0000819"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":14,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":40,"sourceGroups":{"omim":6,"orphanet":20,"published":14}},"features":[{"hpoId":"HP:0012743","label":"Abdominal obesity","primary":true},{"hpoId":"HP:0003119","label":"Abnormal circulating lipid concentration","primary":true},{"hpoId":"HP:0012881","label":"Abnormal labia majora morphology","primary":true},{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":true},{"hpoId":"HP:0030685","label":"Decreased adiponectin level","primary":true},{"hpoId":"HP:0003292","label":"Decreased serum leptin","primary":true},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":true},{"hpoId":"HP:0003551","label":"Difficulty climbing stairs","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0001397","label":"Hepatic steatosis","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0003077","label":"Hyperlipidemia","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0001010","label":"Hypopigmentation of the skin","primary":false},{"hpoId":"HP:0000468","label":"Increased adipose tissue around the neck","primary":false},{"hpoId":"HP:0008993","label":"Increased intraabdominal fat","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0009125","label":"Lipodystrophy","primary":false},{"hpoId":"HP:0009017","label":"Loss of gluteal subcutaneous adipose tissue","primary":false},{"hpoId":"HP:0003635","label":"Loss of subcutaneous adipose tissue in limbs","primary":false},{"hpoId":"HP:0007340","label":"Lower limb muscle weakness","primary":false},{"hpoId":"HP:0002938","label":"Lumbar hyperlordosis","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0000876","label":"Oligomenorrhea","primary":false},{"hpoId":"HP:0001761","label":"Pes cavus","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0008994","label":"Proximal lower limb muscle weakness","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0008997","label":"Proximal upper limb muscle weakness","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false},{"hpoId":"HP:0003712","label":"Skeletal muscle hypertrophy","primary":false}],"ledeHtml":"A rare, genetic lipodystrophy characterized by abnormal subcutaneous fat distribution, resulting in excess accumulation of fat in the face, neck, shoulders, axillae, trunk and pubic region, and loss of subcutaneous fat from the lower extremities. Variable common additional features are progressive adult onset myopathy, insulin resistance, diabetes, hypertriglyceridemia, hepatic steatosis, and vitiligo.","mondoId":"MONDO:0014431","node":{"canonicalSlug":"lipe-related-familial-partial-lipodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"LIPE-related familial partial lipodystrophy","originalSourceId":"ORPHA:435660","paragraphs":["A rare, genetic lipodystrophy characterized by abnormal subcutaneous fat distribution, resulting in excess accumulation of fat in the face, neck, shoulders, axillae, trunk and pubic region, and loss of subcutaneous fat from the lower extremities. Variable common additional features are progressive adult onset myopathy, insulin resistance, diabetes, hypertriglyceridemia, hepatic steatosis, and vitiligo."],"rawAttribution":"ORPHA:435660","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:50Z","upstream":"ORPHA:435660","url":"https://rarediseases.info.nih.gov/diseases/13126"},"ownColumnKeys":["population-ed5d31494f06a636fe49","population-ab0798effa77142bd3ca"],"publication":"published","relationships":[{"kind":"parent","label":"abdominal obesity-metabolic syndrome","mondoId":"MONDO:0000816","slug":null},{"kind":"parent","label":"familial partial lipodystrophy","mondoId":"MONDO:0020088","slug":"familial-partial-lipodystrophy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0cf0b7ae8443af8ffd8a10640dae232fd52da1dd9d8210f3df304a436032d36d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"176fc543ba2dfb4250a62e2056040315e5b2a64c1ec1edc1bbedcd93283e091a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"17d0089846b8b4c07ed74e36777f990d59ca5912000b6f6290d8ab3f830e9fba","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1995ff56fe9bec38956de583ba4650e0d043653d8ed4099d4216c6a593ee3b06","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1fad92d965e6791b90f8db8cfee1c4bf5851d84684a0690c08279c69d9832b9e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"24084e7ea4d9a30c83a7f31764b50e59a143629d55fea9443fcd50cdc100de4c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2b29ab52da59b0197f1eee1a357f582babec06a9cbc54f0ddd2c9d6de50967ee","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0001761","is_excluded":false,"label":"Pes cavus","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2bf4425c9e71b8e240ea01106cce4f7ecfafd25000e228622184123ed5644229","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"364dc37b3af69b1a5e578d9367ab618f34a0955604c41e6bc3d26b6801a3bae9","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0003635","is_excluded":false,"label":"Loss of subcutaneous adipose tissue in limbs","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"40ad7881a226b42b7d0e6945f2ed62748ca592745eeed6c6dc43c196e9904aff","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003119","is_excluded":false,"label":"Abnormal circulating lipid concentration","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"43a9f318b6769e0334bc77b6244ee3f5a76ef83aeb4cbfff89f984a4229e7dbc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0009125","is_excluded":false,"label":"Lipodystrophy","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"587a5e1557714c655fa8ef1bb17db2ae5337c43c009efa5a4eba3b3f1342dda4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"6665ad7e2dc4fbdd184b3961a04ce988e6ed46e3ea82450dc4029e66c0dedb15","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0002938","is_excluded":false,"label":"Lumbar hyperlordosis","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"666d9247bd3a303ff7c2704319c3e18e76462eed685dd7da58bb4550c1711d53","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b13113857d10c6366956c4be290d2387f45c4f1704c598011d7ce6127eae6ce","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"6f80700fe2ecbee6e1cb8c3044aade94541518c35779cc9e35292467c9b8e511","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0003077","is_excluded":false,"label":"Hyperlipidemia","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"70fdbeb8953ddf118c60d6011cec970c638ed48b4cac48b4c6764e5705848395","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008994","is_excluded":false,"label":"Proximal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"755a6a5b0e38fb6708a065373338c6f6de37a1eeefe280a260e1beb23cd93f6f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008993","is_excluded":false,"label":"Increased intraabdominal fat","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"788581fe58880305e1d3c8136002085e4f07ded5b7a27edb7cc81420755022ec","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0012743","is_excluded":false,"label":"Abdominal obesity","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7a59a9d6d8c2bd9d004db1853189ddc6bdfb398ad56b541b5363342ed275566c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009017","is_excluded":false,"label":"Loss of gluteal subcutaneous adipose tissue","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7fd09ed3eeec9adde7daff5f5572e1c80c85c44c0066a070f8d6145532ded9e3","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"87d713f5f71441959fd34b67dbf00dcbe9de686ca0a5a1c89007358ad6da27df","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008997","is_excluded":false,"label":"Proximal upper limb muscle weakness","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8909c2b4e5f0f5af620f806b3f5ee31beb9e6867867b65b5e796cf64d7c86ee1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"89f9f335561f32a0352c530205c48763ca2182071782117f1f2fc1870dfda54e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8b37a0e18ec2d63b3f10e3c5cb88674ee43ad7b68ca02595f7a415272694b8f7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0007340","is_excluded":false,"label":"Lower limb muscle weakness","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"96fc231044aa7ec3961dcd74eea7989d09ab9943cd19bc2dcc4f57159c27df90","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012881","is_excluded":false,"label":"Abnormal labia majora morphology","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"99867ea78d8e06a1698caec5a76a5c1e50e95700de2c2100f8c461f75d9f5ac9","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"OMIM:615980","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a216b4653cc321471c5a7b4314d86bb01a97f4b936ec852604fcdebfeb72a831","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001397","is_excluded":false,"label":"Hepatic steatosis","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a7ed306f4be2e660ebf9cd3bdbe5e717488e1229ab5ca353993dfdcdcc4b83bf","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001010","is_excluded":false,"label":"Hypopigmentation of the skin","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ac26014f0f9697aa37516b96287367cf0c0a5e818030830f9940272db2c2f6bf","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b27ab33009e5d3a505a9472ea5774b704321459263f19d8f63b9f41a49ca269e","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000468","is_excluded":false,"label":"Increased adipose tissue around the neck","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b2b334f2a2a19924bab861904a0cac16f38b9989c5381f7d7c0ed2ab6424ae7d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c15e9b6deecd990c9701aa193c0bac89e934c389d9873d2d6ff6cfc1c3dd288f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ce6f33a454b2e93f576094737b4448d093a4e388c2f65fba8429760ff83edc51","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003292","is_excluded":false,"label":"Decreased serum leptin","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cf3084c077c547d2e73e1a15045c728872945f87c1aacc705fb71961ef3c6d47","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000876","is_excluded":false,"label":"Oligomenorrhea","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d161ad7a32f3ca86c7e8011d112cb86b23b6858bbcb5d42c8af501cc58995e37","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"db7f57414e29a6fbaf0bf6715d6a391bea7e63690e7c495b56f2207d43082872","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002155","is_excluded":false,"label":"Hypertriglyceridemia","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e5a18b45c93dee68a010cd34d946f12c930a261dbdccbe97111806f695f8e05b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f83fd02f3b0960b50b553ab84d554057a584cba27185565a7f69fa32c10c6b2f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615980","disease_name":"Lipodystrophy, familial partial, type 6","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"PMID:27862896","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fce2f01e4f907a3a0c69544fa8d0809c640b14d31c8f9c0560cc049a99755b2f","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:435660","disease_name":"LIPE-related familial partial lipodystrophy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030685","is_excluded":false,"label":"Decreased adiponectin level","onset_id":null,"reference":"ORPHA:435660","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13126\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:435660</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, genetic lipodystrophy characterized by abnormal subcutaneous fat distribution, resulting in excess accumulation of fat in the face, neck, shoulders, axillae, trunk and pubic region, and loss of subcutaneous fat from the lower extremities. Variable common additional features are progressive adult onset myopathy, insulin resistance, diabetes, hypertriglyceridemia, hepatic steatosis, and vitiligo.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13126\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"lipe-related-familial-partial-lipodystrophy","sourceDocuments":[{"name":"GARD: LIPE-related familial partial lipodystrophy","reviewed":null,"source_release":"2026-10-25T03:41:50Z","url":"https://rarediseases.info.nih.gov/diseases/13126"}],"sourceNote":"","synonyms":["FPLD6","LIPE-related FPLD","lipodystrophy, familial partial, type 6"],"takeawayHtml":"","title":"LIPE-related familial partial lipodystrophy"},"schemaVersion":1}
